Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

A clinical trial will test whether a lab-made version of a molecule found in spider venom can reverse tissue damage after a ...

Tissue engineering and regenerative studies are areas of scientific investigation that aim to repair or replace damaged tissues and organs. Scientists speculate that peptide blends might play a key ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

MarketThe peptide receptor radionuclide therapy (PRRT) market is projected to be valued at approximately USD 591.83 million ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

In 2020 the total market size for GLP-1 drugs was less than $4 billion . That same year, Novo Nordisk® paid $1.8 billion to purchase Emisphere's® SNAC drug delivery technology which was subsequently ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...